Login  |   |  Search

Patient Impact Initiative

MOU and Grant Process Downloads

The Patient Impact Initiative is a collaboration of donors, researchers, institutions, clinicians and patients working together to find, fund and finish Rediscovery Research.  

We sent out our second Request for Applications on February 1, 2012.  The Letters of Intent were due in March 2012.  18 potential grantees were asked to cubmit a complete grant to be reviewed and ranked so that the best one can be added to the PII Rediscovery Research™ Portfolio.  

At the moment the PII Rediscovery Research Portfolio contains 22 Rediscovery Research projects in Breast Cancer, Bronchiolitis Obliterans (lung), C diff infection (gastrointestinal), Cerebral Palsy, Cervical Cancer, children’s blood diseases, CLL and CML (blood cancers), Cystic Fibrosis, Epilepsy, IBD (gastrointestinal), Muscular Dystrophy, Premature births, Sarcoidosis (autoimmune disease of the lungs and other organs), Sickle Cell Anemia, SLE (Lupus), and Type 1 Diabetes.  We have 6 additional projects that might be included after resubmission in Schizophrenia, pulmonary hypertension, Sjögren’s Syndrome, Hydrocephalus, Brain Tumors, and Pulmonary Fibrosis.

A Rediscovery Research breast cancer at U Chicago, children’s blood diseases at CHOP, Batten Disease projects at Weill Cornell and U of SD, MDS projects at Einstein and at Columbia, lung cancer at Rush, Cleveland Clinic and at Johns Hopkins, and Type 1 and Type 2 Diabetes projects at University of Texas SW are already fully funded, and a CLL project, a melanoma project and a pediatric brain cancer project are partially funded!  
 

We have signed MOUs and other agreements with Mayo Clinic, Cleveland Clinic, University of Chicago, Mass General, Rush University Medical Center, UMass Medical Center, University of Southern CA, University of Texas Medical Branch, the Menninger Clinic, Saint Louis University, Sanford Burnham Institute, Ohio State University, University of Cincinnati, University of Washington, Los Angeles Basin Clinical and Translational Science Institute, and Dalhousie University and are completing agreements with CHOP/U Penn, Weill Cornell, and the University of South Carolina, and more to follow..  

For a description of our Patient Impact Initiative grant process, click here

If you believe your institution should be a Partner in the Patient Impact Initiative, please download the Partner Invitation package, including the MOU to be signed by the institution, click here



If you are a PI or clinician who has already had success with Rediscovery Research, please contact Dr. Bruce Bloom at Bruce@4cures.org